HB685
Log in to followAN ACT relating to the 340B Drug Pricing Program.
Create a new section of KRS Chapter 216 to define terms; require nonprofit hospitals to submit a 340B Drug Pricing Program report to the Cabinet for Health and Family Services by July 1, 2026, and annually thereafter; direct the Personnel Cabinet to submit a report to the Legislative Research Commission on the impact of the 340B Drug Pricing Program on the Kentucky Employee Health Plan no later than December 1, 2025; require the Cabinet for…
Introduced: February 18, 2025
Last action: February 26, 2025
Plain-language summary
This bill would require nonprofit hospitals in Kentucky to report how they participate in the federal 340B Drug Pricing Program, which allows certain hospitals to buy prescription drugs at reduced prices. It also directs state agencies to study how the program affects the Kentucky Employee Health Plan and Medicaid, with reports due in late 2025 and 2026. The goal is to give lawmakers better information about how the program is being used in the state. Who it may affect: nonprofit hospitals, state employees covered by the Kentucky Employee Health Plan, and Medicaid enrollees.
Open official bill text (PDF)·Report a problem with the summary
Legislative History
Primary Sponsor
Bill Text Versions
Something wrong on this page? Tell us